Skip to main content

Technologies

20 results found
Microfluidics Pharmaceuticals / Nutraceuticals Software
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2020-021 This invention improves unmanned aerial vehicle (UAV) navigation by enabling small, fixed-wing aircraft to communicate with each other about their movements.